Combining immunotherapy with chemotherapy shows promise in enhancing survival rates for extensive-stage small cell lung ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

Your chances depend on what type of lung cancer you have and its stage. The kind of treatment you’ve had may also play a role. There are two types of lung cancer: Non-small-cell lung cancer ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

The Small Cell Lung Cancer market report also offers comprehensive insights into the Small Cell Lung Cancer market size, ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Extensive: Cancer has spread to other places in the body. Learn more about small cell lung cancer staging from the National Cancer Institute. Samantha Murrell shares her journey with stage 4 NSCLC, a ...

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell lung cancer (SCLC). Lead author Shimo Shen, PhD, of China’s Ningbo ...

AstraZeneca AZN announced that the FDA has approved its blockbuster cancer drug Imfinzi (durvalumab) for treating limited-stage small cell lung cancer (LS-SCLC) in adult patients whose disease has ...

Immune-related adverse events (irAEs) were associated with significantly improved progression-free survival (PFS) and overall survival (OS) in patients with extensive-stage small cell lung cancer ...

In the Phase III DeLLphi-304 trial, patients with small cell lung cancer administered Imdelltra achieved a statistically significant and clinically meaningful improvement in overall survival compared ...

2 "With this approval, we can now offer immunotherapy treatment to people living with limited-stage small cell lung cancer, which is almost always fatal, even in patients with limited disease ...